Anthracycline Chemotherapy Triggers Chromatin Shifts Enabling ALDH1-Driven Resistance in Leukemia
Anthracycline-induced chromatin alterations activate ALDH1 enhancers via STAT3 and c-JUN, driving therapy resistance in acute myeloid leukemia cells.
Anthracycline-induced chromatin alterations activate ALDH1 enhancers via STAT3 and c-JUN, driving therapy resistance in acute myeloid leukemia cells.
A comprehensive scientific review outlines how genomic alterations, extrachromosomal DNA, and liquid biopsy strategies expose context-specific vulnerabilities in small cell ...
A study in Brassica rapa demonstrates that heat-induced microspore embryogenesis relies on coordinated DNA hypomethylation, H3K4me3 redistribution, and the activation ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.